Karen L Fearon

This inventor holds 26 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Immunomodulatory Compounds. Top assignees: Dynavax Technologies Corporation, Lynx Therapeutics, Inc., Applied Biosystems, LLC. Active years: 1992-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karen L Fearon. Retrieved from https://idiyas.com/inventor/karen-l-fearon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 26 (Patent Applications = 2)

% Patents Active = 57.7

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 2.9

ph-index = 15

Forward Citations = 700(Granted Patents)

Location History:

Union City, CA (US) (1992 - 1999)
Lafayette, CA (US) (1999 - 2019)
Chico, CA (US) (2022)

Company Filing History:

21 out of 66

Dynavax Technologies Corporation

patents

3 out of 56

Lynx Therapeutics, Inc.

patents

1 out of 532

Applied Biosystems, LLC

patents

4. 1 out of 801

The Perkin-Elmer Corporation

patents

5. 1 out of 18

Trisalus Life Sciences, Inc.

patents

where one patent can have more than one assignee

Years Active: 1992-2022

Loading Chart...

Areas of Expertise:

Immunostimulatory Oligonucleotides

Human Toll-Like Receptor Inhibitors

Chimeric Immunomodulatory Compounds

Biodegradable Formulations

Immunomodulatory Compositions

Polynucleotide Purification

Oligonucleotide Synthesis

Sulfurized Oligonucleotide Analogs

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11312965 - Immunostimulatory sequence oligonucleotides and methods of using the same (2022-04-26),

2. 10196643 - Immunostimulatory sequence oligonucleotides and methods of using the same (2019-02-05),

3. 9868955 - Human toll-like receptor inhibitors and methods of use thereof (2018-01-16),

4. 9422564 - Immunostimulatory sequence oligonucleotides and methods of using the same (2016-08-23),

5. 9228184 - Human toll-like receptor inhibitors and methods of use thereof (2016-01-05),

6. 9028845 - Chimeric immunomodulatory compounds and methods of using the same-IV (2015-05-12),

7. 8871732 - Immunostimulatory sequence oligonucleotides and methods of using the same (2014-10-28),

8. 8669237 - Biodegradable immunomodulatory formulations and methods for use thereof (2014-03-11),

9. 8597665 - Chimeric immunomodulatory compounds and methods of using the same-IV (2013-12-03),

10. 8586555 - Immunomodulatory compositions, formulations, and methods for use thereof (2013-11-19),

11. 8372413 - Immunomodulatory polynucleotides and methods of using the same (2013-02-12),

12. 8222398 - Chimeric immunomodulatory compounds and methods of using the same-II (2012-07-17),

13. 8158768 - Immunostimulatory sequence oligonucleotides and methods of using the same (2012-04-17),

14. 8124590 - Biodegradable immunomodulatory formulations and methods for use thereof (2012-02-28),

15. 8114418 - Chimeric immunomodulatory compounds and methods of using the same—IV (2012-02-14),

Title: Karen L Fearon: A Pioneer in Immunomodulatory Oligonucleotides

Introduction: Karen L Fearon, based in Lafayette, CA, is a prominent inventor with an impressive portfolio of 26 patents. Her work primarily focuses on immunomodulation, a crucial area in biomedical research that has the potential to alter immune responses effectively.

Latest Patents: Among her latest innovations are patents for immunostimulatory sequence oligonucleotides and methods for their use. These inventions provide immunomodulatory polynucleotides and outline methodologies for their application in immunomodulating individuals, aiming to enhance immune responses.

Career Highlights: Throughout her career, Karen has made significant contributions to the field of biotechnology. She has held positions at reputable companies, including Dynavax Technologies Corporation and Lynx Therapeutics, Inc. Her expertise in immunology and oligonucleotide technologies has positioned her as a leader in her field.

Collaborations: Karen has collaborated with notable professionals, including Dino Dina and Stephen F Tuck. These partnerships have allowed her to further extend her research and innovations within the biotechnology sector.

Conclusion: With 26 patents to her name, Karen L Fearon continues to impact the field of immunomodulation significantly. Her inventions not only advance scientific understanding but also pave the way for potential therapeutic applications that could benefit individuals globally.

Profile summary based on public USPTO records.